DaVita Dividends and Buybacks
Dividend criteria checks 0/6
DaVita does not have a record of paying a dividend.
Key information
n/a
Dividend yield
12.4%
Buyback Yield
| Total Shareholder Yield | 12.4% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
DaVita Inc.'s (NYSE:DVA) Prospects Need A Boost To Lift Shares
Apr 14
Returns On Capital At DaVita (NYSE:DVA) Have Stalled
Apr 02We Ran A Stock Scan For Earnings Growth And DaVita (NYSE:DVA) Passed With Ease
Mar 20The DaVita Dilemma: Flat Patient Enrollment And Lawsuits, Yet An Improvement In Net Income Margin
Mar 17Is Now An Opportune Moment To Examine DaVita Inc. (NYSE:DVA)?
Mar 07DaVita: Momentum Could Fade Given High Valuation
Feb 05Does DaVita (NYSE:DVA) Have A Healthy Balance Sheet?
Jan 30Market Still Lacking Some Conviction On DaVita Inc. (NYSE:DVA)
Dec 15DaVita's (NYSE:DVA) Returns On Capital Are Heading Higher
Nov 30DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation
Nov 14Is DaVita Inc. (NYSE:DVA) Potentially Undervalued?
Nov 13Is DaVita (NYSE:DVA) A Risky Investment?
Oct 29An Intrinsic Calculation For DaVita Inc. (NYSE:DVA) Suggests It's 47% Undervalued
Sep 16DaVita Inc.'s (NYSE:DVA) Shares Lagging The Market But So Is The Business
Sep 01
Critical Investments And Policy Changes Propel Healthcare Innovator Towards Brighter Financial Horizons
Aug 22 DaVita's investments in technology and workforce initiatives aim to enhance revenue operations and patient care, contributing to future growth and profitability.DaVita (NYSE:DVA) Has A Pretty Healthy Balance Sheet
Jul 02Is There Now An Opportunity In DaVita Inc. (NYSE:DVA)?
Jun 19Are DaVita Inc. (NYSE:DVA) Investors Paying Above The Intrinsic Value?
Jun 04Returns On Capital At DaVita (NYSE:DVA) Have Hit The Brakes
May 22DaVita Stock Is A Hold As It Expands In Latin America
Mar 18DaVita: Assessing After The Rally
Dec 29DaVita: Simple And Compelling After Sell-Off
Oct 26DaVita: Continued Economic Hurdles, Market Expectations May Be Correct
Oct 05DaVita: Breakout Not Supported Without Leverage Effects, Reiterate Hold
Jul 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if DVA's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if DVA's dividend payments have been increasing.
Dividend Yield vs Market
| DaVita Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (DVA) | n/a |
| Market Bottom 25% (US) | 1.7% |
| Market Top 25% (US) | 5.0% |
| Industry Average (Healthcare) | 1.7% |
| Analyst forecast (DVA) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate DVA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate DVA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate DVA's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as DVA has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/04/15 21:27 |
| End of Day Share Price | 2025/04/15 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
DaVita Inc. is covered by 35 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Stephan Gasteyger | Atlantic Equities LLP |
| Brian Williams | Avondale Partners |
| Matthew Gillmor | Baird |